Endocannabinoid System as Novel Therapeutic Target for Autism Treatment

Dario Siniscalco^1,2,3*

¹Department of Experimental Medicine, Second University of Naples, Italy

²Centre for Autism – La Forza del Silenzio, Caserta, Italy

³Cancellautismo – No Profit Association for Autism Care, Florence, Italy

^*Corresponding Author: Dario Siniscalco, Department of Experimental Medicine-Division of Pharmacology, Second University of Naples, Via S. Maria Di Costantinopoli, 16 - 80138 Napoli, Italy, Tel: +39 (0)81 5665880, Fax: +39 (0)81 5667503 Email:

Editorial